➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
AstraZeneca
Dow
Medtronic
Moodys

Last Updated: May 10, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR IRRIGATING SOLUTION G IN PLASTIC CONTAINER

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Irrigating Solution G In Plastic Container

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00333203 Next Generation Ophthalmic Irrigating Solution Posterior Segment Study Completed Alcon Research Phase 3 2005-10-01 The purpose of this study is to evaluate the safety of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS PLUS for use during surgery for removal of epimacular membrane and vitrectomy.
NCT00333268 Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus Completed Alcon Research Phase 3 2004-09-01 The purpose of this study is to determine the safety and efficacy of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS Plus for use during cataract extraction and intra-ocular lens (IOL) implantation.
NCT00346528 Safety of NGOIS Compared to BSS Plus in Pediatric Patients Completed Alcon Research Phase 3 2006-07-01 To evaluate the Safety of Next Generation Ophthalmic Irrigating Solution compared to BSS Plus for use during cataract surgery in Pediatric patients.
NCT00588016 Concentration of Itraconazole Solution in Nasal Secretions Completed Mayo Clinic Phase 1 2007-04-01 The primary objective of this study is to determine the concentration of itraconazole irrigation in nasal mucous specimens via collection and High-performance liquid chromatography (HPLC) assay. Eight (8) patients with chronic rhinosinusitis (CRS) and two (2) healthy controls will be enrolled in the initial evaluation. After an initial control nasal specimen, followed by seven days of twice daily topical itraconazole irrigation, nasal specimens will be collected at varying time intervals and the concentrations measured. The primary endpoint is development of a reliable collection and assay technique with concentration curves over time of topically administered itraconazole. A secondary endpoint is to determine if the concentrations measured achieve a mean inhibitory concentration (MIC90) to commonly cultured fungal species in the nose.
NCT00801359 BSSPlus Versus Lactated Ringer's for Phacoemulsification Completed University of Sao Paulo Phase 2 2008-01-01 Two intraocular irrigating solutions (BSSPlus versus Lactated Ringer's) are compared in this prospective, randomized, masked trial to investigate for differences in preservation of corneal integrity after phacoemulsification cataract surgery.
NCT00986076 Clinical Trial on Anti-inflammatory Effect of Low-Molecular Weight Heparin in Pediatric Cataract Surgery Completed Iladevi Cataract and IOL Research Center Phase 4 2008-03-01 The purpose of this study is to determine if intraocular infusion of low-molecular weight heparin (enoxaparin) influences postoperative inflammation following pediatric cataract surgery with intraocular lens (IOL) implantation.
NCT01334658 Study of Corneas Undergoing Balanced Salt Solution(BSS ®) Versus Glucose-bicarbonate-Ringer Lactate in Cataract Surgery Completed CLIHON N/A 2010-08-01 This is a study aimed at evaluating the effectiveness and impact of two intraocular irrigating solution (BSS ® versus glucose-bicarbonate-Ringer Lactate - GBRL) on the health of the cornea after cataract surgery by phacoemulsification.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Irrigating Solution G In Plastic Container

Condition Name

Condition Name for Irrigating Solution G In Plastic Container
Intervention Trials
Cataract 5
Hypertension 1
Eye Diseases 1
Surgical Site Infection 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Irrigating Solution G In Plastic Container
Intervention Trials
Cataract 6
Mydriasis 1
Surgical Wound Infection 1
Inflammation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Irrigating Solution G In Plastic Container

Trials by Country

Trials by Country for Irrigating Solution G In Plastic Container
Location Trials
United States 5
Egypt 1
India 1
Turkey 1
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Irrigating Solution G In Plastic Container
Location Trials
Texas 3
Maryland 1
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Irrigating Solution G In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Irrigating Solution G In Plastic Container
Clinical Trial Phase Trials
Phase 4 2
Phase 3 3
Phase 2 4
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Irrigating Solution G In Plastic Container
Clinical Trial Phase Trials
Completed 8
Recruiting 2
Active, not recruiting 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Irrigating Solution G In Plastic Container

Sponsor Name

Sponsor Name for Irrigating Solution G In Plastic Container
Sponsor Trials
Alcon Research 3
Grupo de Estudos em Oftalmologia Clínica e Cirúrgica 1
Mansoura University Hospital 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Irrigating Solution G In Plastic Container
Sponsor Trials
Other 11
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Medtronic
Johnson and Johnson
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.